Colony Group’s GE HealthCare GEHC Stock Holding History

Colony Group’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,073	Closed	-$575K	–	768
2023 Q2	$575K	Sell	7,073 -461	-6%	-$36.8K	0.01%	542
2023 Q1	$618K	Buy	+7,534	New	+$538K	0.01%	533

Other funds holding GEHC

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Colony Group's GEHC Position: Q3 2023 in Review

Colony Group sold out of GE HealthCare (GEHC) in Q3 2023, closing a stake of 7,073 shares — an estimated $575K sold.

Colony Group first reported a position in GEHC in Q1 2023 and held it in 2 quarters. The position peaked at $618K in Q1 2023. 1,105 funds tracked by Wall St. Rank hold GEHC as of Q3 2023.

Colony Group reported no remaining GE HealthCare position as of Q3 2023 after selling out during the quarter.
Colony Group sold 7,073 GE HealthCare shares in Q3 2023, an estimated $575K.
Colony Group first reported a position in GE HealthCare in Q1 2023 and held it in 2 quarters.
Colony Group's GE HealthCare position peaked at $618K in Q1 2023.
1,105 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.